Skip to content

Study on the Mechanism of Acupuncture in Ameliorating Chronic Airway Inflammation in Asthma by Modulating the "Lung-Brain Axis"

Study on the Mechanism of Acupuncture in Ameliorating Chronic Airway Inflammation in Asthma by Modulating the "Lung-Brain Axis"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000737
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-04-15
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

control group:placebo acupuncture treatment

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) 18 years = age = 65 years; 2) Right sharp hand; 3) Meet the criteria for mild and moderate grading of chronic persistent asthma in the Guidelines for the Prevention and Control of Bronchial Asthma (2020 edition); 4) Those who have not participated in other clinical studies within the last 1 month; 5) Informed consent signed by the patient himself/herself or signed by his/her immediate family members on his/her behalf. Note: Subjects who also meet the above five items can be included in this study.

Exclusion criteria

Exclusion criteria: 1) Patients with intermittent severe persistent and acute exacerbations of bronchial asthma; 2) Combined with other significant lung diseases such as bronchiectasis tuberculosis lung abscess cystic fibrosis alpha-1 antitrypsin deficiency or restrictive lung disease (iii) Have a clinically or functionally uncontrollable respiratory haematological immunological renal neurological psychiatric hepatic endocrine cancer or other disease or any other possible condition (e.g. major surgery) that in the judgement of the investigator may place the patient at undue risk or affect the results of the study or the interpretation of the results; 4) Patients who currently have or have had uncontrolled heart failure clinically significant coronary artery disease recent myocardial infarction severe hypertension and uncontrolled cardiac arrhythmias; 5) Asthma presenting only from incidental exposure to allergens or chemical sensitisers; (vi) Lower respiratory tract infections (e.g. pneumonia) affecting the patient's asthma or the use of systemic glucocorticoids (=10 days) for an acute exacerbation of severe asthma within 1 month prior to enrolment; (vii) Pregnant and lactating women and those who have had a request for childbirth in the last six months; (8) Those with contraindications to magnetic resonance and pulmonary function tests; Those who have received acupuncture treatment for asthma in the past 1 month. Note: Subjects who meet any of the above criteria should be excluded.

Design outcomes

Primary

MeasureTime frame
Asthma Quality of Life Questionnaire;Asthma Control Test;

Secondary

MeasureTime frame
Self-Rating Anxiety Scale;Pittsburgh Sleep Quality Index;Self-Rating Depression Scale;Montreal Cognitive Assessment;

Countries

China

Contacts

Public ContactXiaohui Dong

Chengdu University of Traditional Chinese Medicine

dongxiaohui0405@126.com18215528986

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026